Skip to main content

MINI REVIEW article

Front. Nutr.

Sec. Nutrition and Metabolism

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1584379

Yerba Mate (Ilex paraguariensis): Unraveling Its Synergistic Mechanisms for Metabolic Health

Provisionally accepted
Dan Li Dan Li 1*Dan Hughes Dan Hughes 1Steward Hughes Steward Hughes 2
  • 1 Performance labs pte ltd, Singapore, Singapore
  • 2 Unicity, Provo, Utah, United States

The final, formatted version of the article will be published soon.

    Metabolic disorders, including obesity, dyslipidemia, insulin resistance, and type 2 diabetes, impact over 1 billion people worldwide as of 2025, driven by intricate genetic, environmental, and lifestyle interactions. Yerba mate (Ilex paraguariensis), a traditional South American beverage rich in polyphenols (e.g., chlorogenic acid, rutin), saponins, and methylxanthines (e.g., caffeine), has garnered attention for its potential in metabolic syndrome management due to its bioactive-driven, synergistic mechanisms. This mini-review synthesizes evidence from published studies on yerba mate's metabolic effects across eight pathways: gut microbiota and hormonal signaling, hypothalamic appetite regulation, oxidative stress reduction, inflammation reduction, lipid metabolism reprogramming, glycemic regulation, mitochondrial efficiency, and neurotransmitter modulation. Data from human trials, murine models, and in vitro studies were analyzed to evaluate benefits, controversies, and research gaps. Recent findings show yerba mate enhances microbiotamediated GLP-1 secretion, restores leptin sensitivity via hypothalamic inflammation reduction, and boosts mitochondrial efficiency, yielding lower HbA1c, triglycerides, and adiposity. However, efficacy debates persist, with variable microbiota responses and inconsistent outcomes across populations challenging its standardization. Limited long-term human data fuels skepticism against its preventive promise compared to conventional therapies. Yerba mate exemplifies a holistic nutraceutical approach, merging tradition with modern science. Addressing gaps in long-term efficacy, dosing consistency, and population-specific effects is critical. Future research leveraging AI personalization, synergistic bioactives (e.g., prebiotics, omega-3s), and robust trials could elevate its role in combating the global metabolic health crisis.

    Keywords: Yerba mate, Metabolic health, GLP-1, Leptin, Lipid Metabolism, Adipogenesis, Glycogenesis, Gluconeogenesis

    Received: 28 Feb 2025; Accepted: 14 Mar 2025.

    Copyright: © 2025 Li, Hughes and Hughes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Dan Li, Performance labs pte ltd, Singapore, Singapore

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more